KK
IMNM icon

KLP Kapitalforvaltning’s Immunome IMNM Stock Holding History

KLP Kapitalforvaltning’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446K Buy
20,400
+5,400
+36% +$120K ﹤0.01% 1475
2025
Q4 		$322K Buy
15,000
+1,800
+14% +$31.6K ﹤0.01% 1630
2025
Q3 		$155K Hold
13,200
– – ﹤0.01% 1913
2025
Q2 		$123K Sell
13,200
-3,900
-23% -$32K ﹤0.01% 1971
2025
Q1 		$115K Buy
17,100
+10,000
+141% +$95.9K ﹤0.01% 1970
2024
Q4 		$75.4K Buy
+7,100
New +$85.8K ﹤0.01% 2168

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

KLP Kapitalforvaltning's IMNM Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Immunome (IMNM) stake by 36% in Q1 2026, buying an estimated $120K and bringing the position to 20,400 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

KLP Kapitalforvaltning first reported a position in IMNM in Q4 2024 and has held it in 6 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • KLP Kapitalforvaltning held 20,400 shares of Immunome worth $446K as of Q1 2026.
  • KLP Kapitalforvaltning bought 5,400 Immunome shares in Q1 2026, an estimated $120K.
  • Immunome made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1475 holding.
  • KLP Kapitalforvaltning first reported a position in Immunome in Q4 2024 and has held it in 6 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.